Medical Care Technologies Inc.
Medical Care Technologies works in the collectibles and memorabilia market, using artificial intelligence to assess the authenticity of memorabilia and engaging in sales of high-value items. Its activities include both authentication and transactions involving collectible memorabilia. The company is based in Mesa, Arizona.
No SEC Form 4 filings for $MDCE in the last 30 days.
See all $MDCE insider activity →Medical Care Technologies Inc. (MDCE) expects potential profits of over $5M from selling $20M in private collectibles assets. Profits are contingent on completed sales and not guaranteed. This follows a prior game-worn memorabilia transaction with a large collectibles partner, according to the company.
Medical Care Technologies Inc. (MDCE) reported its focus on AI-driven software and subsidiaries ahead of Q3 results. The company has a $250,000 software agreement, enterprise consulting, and revenue from Infinite Auctions and Real Game Used. 2025 revenue was $1.07M with net income of $230,768. Q3 2026 results are expected to show the strongest quarterly revenue of the past year, according to the company.
Medical Care Technologies (MDCE) reported improved image quality and processing metrics for its Melanoma Scan Beta platform, with 86% of photos meeting quality standards, 89% successfully mapped, and 91% aligned for sequential comparison. The company continues beta testing and data collection, but the platform is still in development and lacks regulatory clearance.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning MDCE (Medical Care Technologies Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent MDCE coverage spans financial news, technology and earnings.
Potential modest profit from asset sales.
Medical Care Technologies Inc. (MDCE) reported its focus on AI-driven software and subsidiaries ahead of Q3 results. The company has a $250,000 software agreement, enterprise consulting, and revenue from Infinite Auctions and Real Game Used. 2025 revenue was $1.07M with net income of $230,768. Q3 2026 results are expected to show the strongest quarterly revenue of the past year, according to the company.
Progress in technical image-processing metrics supports continued beta development, but no clinical or regulatory validation is provided.
Medical Care Technologies (MDCE) announced it is hiring software technicians to accelerate its technology platforms and enterprise services. This follows the company's first paid software agreement, valued at up to $250,000, and recent commercial milestones. The company aims to increase development speed and respond to client demands.
Medical Care Technologies Inc. (MDCE) is expanding its business model to include AI consulting services, alongside its existing AI software sales. The new offerings aim to help companies train AI models and integrate them into their operations. According to the CEO, this move follows the company's first paid external software agreement. MDCE is a diversified technology company focused on AI applications in various sectors.
AlphAI scores every news story that mentions MDCE with an AI model for sentiment and relevance, and aggregates insider trades from Medical Care Technologies Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Medical Care Technologies Inc. (MDCE) expects potential profits of over $5M from selling $20M in private collectibles assets. Profits are contingent on completed sales and not guaranteed. This follows a prior game-worn memorabilia transaction with a large collectibles partner, according to the company.
Medical Care Technologies Inc. (MDCE) reported its focus on AI-driven software and subsidiaries ahead of Q3 results. The company has a $250,000 software agreement, enterprise consulting, and revenue from Infinite Auctions and Real Game Used. 2025 revenue was $1.07M with net income of $230,768. Q3 2026 results are expected to show the strongest quarterly revenue of the past year, according to the company.
Medical Care Technologies (MDCE) reported improved image quality and processing metrics for its Melanoma Scan Beta platform, with 86% of photos meeting quality standards, 89% successfully mapped, and 91% aligned for sequential comparison. The company continues beta testing and data collection, but the platform is still in development and lacks regulatory clearance.
Medical Care Technologies (MDCE) announced it is hiring software technicians to accelerate its technology platforms and enterprise services. This follows the company's first paid software agreement, valued at up to $250,000, and recent commercial milestones. The company aims to increase development speed and respond to client demands.
Medical Care Technologies Inc. (MDCE) is expanding its business model to include AI consulting services, alongside its existing AI software sales. The new offerings aim to help companies train AI models and integrate them into their operations. According to the CEO, this move follows the company's first paid external software agreement. MDCE is a diversified technology company focused on AI applications in various sectors.
Medical Care Technologies Inc. anticipates its Q3 2026 revenue will exceed any quarter in the past year, attributed to new software sales and a collectibles partnership. The company did not disclose specific figures, with full results to be released in the coming weeks, according to the company.
Medical Care Technologies Inc. (MDCE) secured its first paid AI software contract, valued at up to $250,000, with the initial payment already initiated. The company did not disclose the application specifics but mentioned additional ongoing incentives. According to the company, this is a multi-year agreement.
Medical Care Technologies Inc. (MDCE) subsidiary Infinite Auctions is in advanced talks with Fanatics/Topps to supply Knicks 2026 championship game-worn memorabilia for potential card products. No agreement has been signed yet.
Medical Care Technologies Inc. (MDCE) announced its MDCE Melanoma Scan Beta platform is seeking volunteers for human-submitted dataset testing, moving beyond public cancer imaging datasets.
Medical Care Technologies (MDCE) is seeking volunteers to test its Melanoma Scan Beta platform with real-world skin images. The company aims to assess image variability and AI model performance, though the app is in beta and lacks regulatory clearance. MDCE generates revenue through subsidiaries while advancing AI capabilities.
